Jessie Becker, chief executive officer of InPress Technologies, which is developing a medical device to stop postpartum hemorrhaging, made the 30 Under 30 list for her work in healthcare.
Dundon, 29, is chief executive officer of the company he co-founded in 2009. He credits business partner Kevin Rice, adviser Tom Leach, family, friends and colleagues with the firm's success.
With offices in San Luis Obispo and Tokyo, Hathway has nearly 50 employees and revenue of $6 million in 2014. Clients include TransUnion, Behr Paint, Applied Materials and Transamerica.
"This list is only the beginning," Dundon noted in a company news release. "I'm now charged with a huge responsibility to move forward and leverage this to achieve something truly amazing and make the world a better place."
Becker, 25, was instrumental in growing InPress through Cal Poly's Center for Innovation and Entrepreneurship, including its HotHouse Accelerator Program. The concept for the device was developed when Becker was a Cal Poly student in 2011 and moonlighting for the startup. When the two original founders decided to pursue other opportunities, Becker kept going.
"The InPress device aims to quickly and effectively stop postpartum hemorrhage, the leading cause of maternal death globally," said Becker in a company statement. "To be named one of the Forbes magazine's top 30 young disruptors of healthcare today is both an honor and a tremendous validation of our simple device's potential to save the lives of women around the world. It is also a testament to the exceptional team behind its development."
The venture, with three employees and offices in San Luis Obispo and Mountain View at The Fogarty Institute for Innovation, raised $1.5 million in funding last year.
This year, Becker is working on obtaining regulatory approvals so that InPress can begin selling the device in the United States and Europe.